{
    "id": "5c891e5575a4a5d219000012",
    "question": "Do Crocus sativus extracts loosen the blood-brain barrier?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the information provided in the documents about the blood-brain barrier and its characteristics. The blood-brain barrier is a highly selective permeable barrier that restricts the passage of certain substances from the bloodstream to the brain. The barrier is composed of endothelial cells, tight junctions, and astrocytes, and it regulates the movement of ions, nutrients, and waste products between the blood and the brain. The barrier is impermeable to large molecules and ions, but it allows the passage of small molecules, such as oxygen, carbon dioxide, and certain lipid-soluble molecules. The barrier also regulates the concentration of potassium ions in the brain extracellular fluid. Given this information, we need to determine if Crocus sativus extracts can loosen the blood-brain barrier. To do this, we need to look for information about the effects of Crocus sativus extracts on the blood-brain barrier in the provided documents. After reviewing the documents, I found that there is no information about the effects of Crocus sativus extracts on the blood-brain barrier. Therefore, based on the available information, we cannot conclude that Crocus sativus extracts loosen the blood-brain barrier. However, based on general knowledge, Crocus sativus, also known as saffron, has been shown to have neuroprotective effects and may have potential therapeutic applications for neurodegenerative diseases. Some studies suggest that Crocus sativus extracts may have antioxidant, anti-inflammatory, and anti-apoptotic properties, which could potentially impact the blood-brain barrier. However, these effects are not directly related to loosening the blood-brain barrier. In conclusion, based on the provided documents, there is no direct evidence that Crocus sativus extracts loosen the blood-brain barrier. However, further research is needed to fully understand the effects of Crocus sativus extracts on the blood-brain barrier.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Neurology_Adams_9494",
            "title": "Neurology_Adams",
            "content": "To enter the extracellular compartment of the nervous system, a drug or toxic agent must transgress the tight capillary\u2013endothelial barrier (blood\u2013brain barrier) and the barrier between the blood and cerebrospinal fluid (blood\u2013CSF barrier). Intrathecal injection circumvents these barriers, but then the agent tends to concentrate in the immediate subpial and subependymal regions. The process of movement from plasma to brain is by diffusion through capillaries or by facilitated transport. The solubility characteristics of the drug determine its rate of diffusion."
        },
        {
            "id": "Histology_Ross_1889",
            "title": "Histology_Ross",
            "content": "The blood\u2013brain barrier restricts passage of certain ions and substances from the bloodstream to tissues of the CNS. The presence of only a few small vesicles indicates that pinocytosis across the brain endothelial cells is severely restricted. Substances with a molecular weight greater than 500 daltons generally cannot cross the blood\u2013brain barrier. Many molecules that are required for neuronal integrity leave and enter the blood capillaries through the endothelial cells. Thus, O2 and CO2 as well as certain lipid-soluble molecules (e.g., ethanol and steroid hormones) easily penetrate the endothelial cells and pass freely between the blood and extracellular fluid of the CNS. Due to the high K permeability of the neuronal membrane, neurons are particularly sensitive to changes in the concentration of extracellular K. As previously discussed, astrocytes are foot processes of astrocytes FIGURE 12.32 \u2022 Schematic drawing of blood\u2013brain barrier."
        },
        {
            "id": "Physiology_Levy_2715",
            "title": "Physiology_Levy",
            "content": "Fig. 25.5 ). The blood-brain barrier is composed of endothelial cells, smooth muscle, and the pial and arachnoid membranes, and it regulates the movement of ions between blood and CSF. In addition, the choroid plexus also determines the ionic composition of CSF by transporting ions into and out of CSF. The blood-brain barrier is relatively impermeable by H+ and HCO3 \u2212 ions, but it is very permeable by CO2. Thus the PCO2 in CSF parallels the arterial PCO2 tension. CO2 is also produced by cells of the brain as a product of metabolism. As a consequence, the PCO2 in CSF is usually a few millimeters of mercury higher than that in arterial blood, and so the pH is slightly more acidic (7.33) in CSF than in plasma ("
        },
        {
            "id": "Pharmacology_Katzung_2182",
            "title": "Pharmacology_Katzung",
            "content": "The blood-brain barrier (BBB) is a protective functional separation of the circulating blood from the extracellular fluid of the CNS that limits the penetration of substances, including drugs. This separation is accomplished by the presence of tight junctions between the capillary endothelial cells as well as a surrounding layer of astrocyte end-feet. As such, to enter the CNS, drugs must either be highly hydrophobic or engage specific transport mechanisms. For example, the second-generation antihistamines cause less drowsiness because they were developed to be significantly more polar than older antihistamines, limiting their crossing of the BBB (see Chapter 16). Many nutrients, such as glucose and the essential amino acids, have specific transporters that allow them to cross the BBB. l-DOPA, a precursor of the neurotransmitter dopamine, can enter the brain using an amino acid transporter, whereas dopamine cannot cross the BBB. Thus, the orally administered drug l-DOPA, but not"
        },
        {
            "id": "Neurology_Adams_4811",
            "title": "Neurology_Adams",
            "content": "Studies using radioisotopic tracer techniques confirm that the main constituents of the CSF (see Table 2-2) are in dynamic equilibrium with the blood. Similarly, CSF in the ventricles and subarachnoid spaces is in equilibrium with the intercellular fluid of the brain, spinal cord, and olfactory and optic nerves. Certain structures and physiologic mechanisms that maintain this equilibrium are subsumed under the term blood\u2013brain barrier, which is used to designate all of the interfaces between blood, brain, spinal cord and CSF. The site of the barrier varies for the different plasma constituents. One is the endothelium of the choroidal and brain capillaries; another is the plasma membrane and adventitia (Rouget cells) of these vessels; a third is the pericapillary foot processes of astrocytes. Large molecules, such as albumin, are prevented from entry by the capillary endothelium, and this is the barrier also for such molecules as are bound to album in, for example, aniline dyes (trypan"
        },
        {
            "id": "Histology_Ross_1886",
            "title": "Histology_Ross",
            "content": "The blood\u2013brain barrier protects the CNS from fluctuating levels of electrolytes, hormones, and tissue metabolites circulating in the blood vessels. The observation more than 100 years ago that vital dyes injected into the bloodstream can penetrate and stain nearly all organs except the brain provided the first description of the blood\u2013brain barrier. More recently, advances in microscopy and molecular biology techniques have revealed the precise location of this unique barrier and the role of endothelial cells in transporting essential substances to the brain tissue."
        },
        {
            "id": "Pharmacology_Katzung_52",
            "title": "Pharmacology_Katzung",
            "content": "In only a few situations is it possible to apply a drug directly to its target tissue, eg, by topical application of an anti-inflammatory agent to inflamed skin or mucous membrane. Most often, a drug is administered into one body compartment, eg, the gut, and must move to its site of action in another compartment, eg, the brain in the case of an antiseizure medication. This requires that the drug be absorbed into the blood from its site of administration and distributed to its site of action, permeating through the various barriers that separate these compartments. For a drug given orally to produce an effect in the central nervous system, these barriers include the tissues that make up the wall of the intestine, the walls of the capillaries that per-fuse the gut, and the blood-brain barrier, the walls of the capillaries that perfuse the brain. Finally, after bringing about its effect, a drug should be eliminated at a reasonable rate by metabolic inactivation, by excretion from the"
        },
        {
            "id": "Neurology_Adams_5035",
            "title": "Neurology_Adams",
            "content": "Microvascular transudative factors, such as proteases released by tumor cells, also contribute to vasogenic edema by loosening the blood\u2013brain barrier and allowing passage of blood proteins. The small protein fragments that are generated by this protease activity may exert osmotic effects as they spread through the white matter of the brain. This is the postulated basis of the regional swelling, or localized cerebral edema that surrounds the tumor. Experimentally, the increase in permeability has been shown to vary inversely with the molecular weight of various markers; for example, inulin (molecular weight: 5,000) enters the intercellular space more readily than albumin (molecular weight: 70,000)."
        },
        {
            "id": "Histology_Ross_1890",
            "title": "Histology_Ross",
            "content": "FIGURE 12.32 \u2022 Schematic drawing of blood\u2013brain barrier. This drawing shows the blood\u2013brain barrier, which consists of endothelial cells joined together by elaborate, complex tight junctions, endothelial basal lamina, and the end foot processes of astrocytes. responsible for buffering the concentration of K in the brain extracellular fluid (page 369). They are assisted by endothelial cells of the blood\u2013brain barrier that effectively limit movement of K into the extracellular fluid of the CNS. Substances that do cross the capillary wall are actively transported by specific receptor-mediated endocytosis. For instance, glucose (which the neuron depends on almost exclusively for energy), amino acids, nucleosides, and vitamins are actively transported by specific transmembrane carrier proteins. The permeability of the blood\u2013brain barrier to these macromolecules is attributable to the level of expression of specific carrier proteins on the endothelial cell surface."
        },
        {
            "id": "Pharmacology_Katzung_2987",
            "title": "Pharmacology_Katzung",
            "content": "only about 1\u20133% of administered levodopa actually enters the brain unaltered; the remainder is metabolized extracerebrally, predominantly by decarboxylation to dopamine, which does not penetrate the blood-brain barrier. Accordingly, levodopa must be given in large amounts when used alone. However, when given in combination with a dopa decarboxylase inhibitor that does not penetrate the blood-brain barrier, the peripheral metabolism of levodopa is reduced, plasma levels of levodopa are higher, plasma half-life is longer, and more dopa is available for entry into the brain (Figure 28\u20134). Indeed, concomitant administration of a peripheral dopa decarboxylase inhibitor such as carbidopa may reduce the daily requirements of levodopa by approximately 75%."
        },
        {
            "id": "Histology_Ross_1888",
            "title": "Histology_Ross",
            "content": "Evidence suggests that the integrity of blood\u2013brain barrier tight junctions depends on normal functioning of the associated astrocytes. In several brain diseases, the blood\u2013brain barrier loses effectiveness. Examination of brain tissue in these conditions by TEM reveals loss of the tight junctions as well as alterations in the morphology of astrocytes. Other experimental evidence has revealed that astrocytes release soluble factors that increase barrier properties and tight junction protein content."
        },
        {
            "id": "Physiology_Levy_323",
            "title": "Physiology_Levy",
            "content": "The Blood-Brain Barrier The local environment of most CNS neurons is controlled such that neurons are normally protected from extreme variations in the composition of the extracellular fluid that bathes them. Part of this control is provided by the presence of a blood-brain barrier (other mechanisms are the buffering functions of glia, regulation of CNS circulation, and exchange of substances between the CSF and extracellular fluid of the CNS). Movement of large molecules and highly charged ions from blood into the brain and spinal cord is severely restricted. The restriction is at least partly due to the barrier action of the capillary endothelial cells of the CNS and the tight junctions between them. Astrocytes may also help limit the movement of certain substances. For example, astrocytes can take up potassium ions and thus regulate [K+] in the extracellular space. Some pharmaceutical agents, such as penicillin, are removed from the CNS by transport mechanisms."
        },
        {
            "id": "Physiology_Levy_2072",
            "title": "Physiology_Levy",
            "content": "Fig. 17.40 ). Pericytes regulate blood flow by adjusting vascular diameter, and they secrete angiopoetin, a growth factor that stimulates the expression of occludins in endothelial cells. Occludins are prominently expressed in brain endothelial cells, in contrast to their sparse distribution in nonneural endothelium. The neurovascular unit regulates blood flow and capillary permeability. Thus the neurovascular unit is involved in pathological states, including hypoxia, neurodegenerative diseases, and inflammation, that are characterized by dysfunction of the blood-brain barrier."
        },
        {
            "id": "Physiology_Levy_2070",
            "title": "Physiology_Levy",
            "content": "Changes in cerebral blood flow are associated with \u201cfunctional recruitment\u201d of capillaries. Thus the rate of flow through each capillary is adjusted to meet the needs of the organ. In \u201ccapillary recruitment,\u201d in contrast, more capillaries are open to accommodate greater blood flow. The brain has several protective mechanisms that regulate blood flow. These mechanisms include the blood-brain barrier, extrinsic regulation of central cardiovascular centers, intrinsic control (autoregulation) of circulation, and functional hyperemia, in which blood flow increases to a brain region that is active. The blood-brain barrier regulates ion and nutrient transport between the blood and the brain and also limits the entry of harmful substances from the blood into the brain. The \u2022Fig. 17.40 Diagram of a Neurovascular Unit With an Astrocyte Linking a Neuron to an Arteriole of the Brain Microcirculation."
        },
        {
            "id": "Pharmacology_Katzung_1809",
            "title": "Pharmacology_Katzung",
            "content": "catecholamines from the adrenal medulla and stimulate sympathetic ganglia. Bradykinin also increases blood pressure when injected into the central nervous system, but the physiologic significance of this effect is not clear, since it is unlikely that kinins cross the blood-brain barrier. (Note, however, that bradykinin can increase the permeability of the blood-brain barrier to some other substances.) Kinins have no consistent effect on sympathetic or parasympathetic nerve endings."
        },
        {
            "id": "Pathology_Robbins_1850",
            "title": "Pathology_Robbins",
            "content": "blood. Ingested lead is particularly harmful to children because they absorb more than 50% of lead from food, whereas adults absorb approximately 15%. A more permeable blood\u2013brain barrier in children creates a high susceptibility to brain damage. The clinical features of lead poisoning are shown in"
        },
        {
            "id": "Neurology_Adams_9085",
            "title": "Neurology_Adams",
            "content": "Vasodilator drugs, glutamate blockers, opiate antagonists, and calcium channel blockers have been of no proven benefit despite their theoretical appeal and some experimental successes. Corticosteroids ostensibly help to allay brain (possibly cellular) swelling, but, again, their therapeutic benefit has not been evident in clinical trials."
        },
        {
            "id": "Pharmacology_Katzung_7130",
            "title": "Pharmacology_Katzung",
            "content": "1. Antidepressant action\u2014The hypericin fraction was initially reported to have MAO-A and -B inhibitor properties. Later studies found that the concentration required for this inhibition was higher than that achieved with recommended dosages. In vitro studies using the commercially formulated hydroalcoholic extract have shown inhibition of nerve terminal reuptake of serotonin, norepinephrine, and dopamine. While the hypericin constituent did not show reuptake inhibition for any of these systems, the hyperforin constituent did. Chronic administration of the commercial extract has also been reported to significantly down-regulate the expression of cortical \u03b2 adrenoceptors and up-regulate the expression of serotonin receptors (5-HT2) in a rodent model. Other effects observed in vitro include sigma receptor binding using the hypericin fraction and GABA receptor binding using the commercial extract. Interleukin-6 production is also reduced in the presence of the extract. a."
        },
        {
            "id": "Histology_Ross_1891",
            "title": "Histology_Ross",
            "content": "Several other proteins that reside within the plasma membrane of endothelial cells protect the brain by metabolizing certain molecules, such as drugs and foreign proteins, thus preventing them from crossing the barrier. For example, L-dopa (levodopa), the precursor of the neuromediators dopamine and noradrenaline, easily crosses the blood\u2013brain barrier. However, the dopamine formed from the decarboxylation of L-dopa in endothelial cells cannot cross the barrier and is restricted from the CNS. In this case, the blood\u2013brain barrier regulates the concentration of L-dopa in the brain. Clinically, this restriction explains why L-dopa is administered for the treatment of dopamine deficiency (e.g., Parkinson\u2019s disease) rather than dopamine."
        },
        {
            "id": "Physiology_Levy_2119",
            "title": "Physiology_Levy",
            "content": "regulation of blood flow is paramount, but it yields to metabolic regulation during muscle contractions (as during exercise). 15. Cerebral blood flow is regulated predominantly by metabolic factors, especially CO2, K+ , and adenosine. The increased regional cerebral activity produced by stimuli such as touch, pain, hand motion, talking, reading, reasoning, and problem solving are associated with enhanced blood flow in the activated area of the contralateral cerebral cortex. The neurovascular unit (microcirculation, pericytes, the extracellular matrix, astrocytes and neurons), a component of the blood-brain barrier, is thought to link brain activity with increased blood flow and oxygenation. 16."
        },
        {
            "id": "Histology_Ross_1893",
            "title": "Histology_Ross",
            "content": "Some parts of the CNS, however, are not isolated from substances carried in the bloodstream. The barrier is ineffective or absent in the sites located along the third and fourth ventricles of the brain, which are collectively called circumventricular organs. Circumventricular organs include the pineal gland, median eminence, subfornical organ, area postrema, subcommissural organ, organum vasculosum of the lamina terminalis, and posterior lobe of the pituitary gland. These barrierdeficient areas are most likely involved in sampling of materials circulating in the blood that are normally excluded by the blood\u2013brain barrier and then conveying information about these substances to the CNS. Circumventricular organs are important in regulating body fluid homeostasis and controlling neurosecretory activity of the nervous system. Some researchers describe them as \u201cwindows of the brain\u201d within central neurohumoral system."
        },
        {
            "id": "Pharmacology_Katzung_1274",
            "title": "Pharmacology_Katzung",
            "content": "All of the cardiac glycosides, or cardenolides\u2014of which digoxin is the prototype\u2014combine a steroid nucleus linked to a lactone ring at the 17 position and a series of sugars at carbon 3 of the nucleus. Because they lack an easily ionizable group, their solubility is not pH-dependent. Digoxin is obtained from Digitalis lanata, the white foxglove, but many common plants (eg, oleander, lily of the valley, milkweed, and others) contain cardiac glycosides with similar properties. Digoxin, the only cardiac glycoside used in the USA, is 65\u201380% absorbed after oral administration. Absorption of other glycosides varies from zero to nearly 100%. Once present in the blood, all cardiac glycosides are widely distributed to tissues, including the central nervous system (CNS)."
        },
        {
            "id": "Pharmacology_Katzung_2982",
            "title": "Pharmacology_Katzung",
            "content": "Dopamine does not cross the blood-brain barrier and if given into the peripheral circulation has no therapeutic effect in parkinsonism. However, (\u2013)-3-(3,4-dihydroxyphenyl)-l-alanine (levodopa), the immediate metabolic precursor of dopamine, does enter the brain (via an l-amino acid transporter, LAT), where it is decarboxylated to dopamine (see Figure 6\u20135). Several noncatecholamine dopamine receptor agonists have also been developed and may lead to clinical benefit, as discussed in the text that follows."
        },
        {
            "id": "Pharmacology_Katzung_2220",
            "title": "Pharmacology_Katzung",
            "content": "Using the criteria above, a vast number of small molecules have been isolated from the brain, and studies using a variety of approaches suggest that the agents listed in Table 21\u20132 are neurotransmitters. A brief summary of some of these compounds follows. The amino acids of primary interest to the pharmacologist fall into two categories: the acidic amino acid glutamate and the neutral amino acids glycine and GABA. These compounds are present in high concentrations in the CNS and are extremely potent modifiers of neuronal excitability. A. Glutamate"
        },
        {
            "id": "Physiology_Levy_3309",
            "title": "Physiology_Levy",
            "content": "the body, including the lung, eye, skin, secretory glands, and brain, where they play key physiological roles. For example, AQP4 is expressed in cells that form the blood-brain barrier. Knockout of AQP4 affects the water permeability of the blood-brain barrier such that brain edema is reduced in AQP4-deficient mice after acute water loading and subsequent development of hyponatremia."
        },
        {
            "id": "InternalMed_Harrison_32363",
            "title": "InternalMed_Harrison",
            "content": "Impaired cerebral autoregulation in the presence of hypoxic cerebral vasodilation and altered permeability of the blood-brain barrier due to hypoxia-induced chemical mediators like histamine, arachidonic acid, and VEGF may all contribute to brain edema. In 1995, VEGF was first proposed as a potent promoter of capillary leakage FIGURE 476e-1 T2 magnetic resonance image of the brain of a patient with high-altitude cerebral edema (HACE) shows marked swelling and a hyperintense posterior body and splenium of the corpus callosum (area with dense opacity). The patient, a climber, went on to climb Mount Everest about 9 months after this episode of HACE."
        },
        {
            "id": "Neurology_Adams_5180",
            "title": "Neurology_Adams",
            "content": "Involvement of the cranial nerves or an encephalopathy caused by widespread infiltration of the cranial meninges has been treated with whole-brain radiation, 3,000 cGy, given in fractions of 300 cGy per day for 10 days. Spinal root infiltration responds to spinal radiation, and regional treatments are helpful temporarily for local seeding of the lumbar roots. A study of CSF flow by the injection of a radionuclide agent may be useful to determine if there is impeded flow that prevents circulation of the methotrexate or exposes one region to excessive toxicity. In tumors that are sensitive to a specific chemotherapy, systemic administration may be effective depending on the permeability of the blood\u2013brain barrier to these agents, for example, in some forms of breast cancer, and the systemic use of check point (cell-cycle, e.g., PD-1) inhibitors is being investigated."
        },
        {
            "id": "InternalMed_Harrison_21159",
            "title": "InternalMed_Harrison",
            "content": "PATHOPHYSIOLOGY Brain Edema Swelling, or edema, of brain tissue occurs with many types of brain injury. The two principal types of edema are vasogenic and cytotoxic. Vasogenic edema refers to the influx of fluid and solutes into the brain through an incompetent blood-brain barrier (BBB). In the normal cerebral vasculature, endothelial tight junctions associated with astrocytes create an impermeable barrier (the BBB), through which access into the brain interstitium is dependent upon specific transport mechanisms. The BBB may be compromised in ischemia, trauma, infection, and metabolic derangements. Vasogenic edema results from abnormal permeability of the BBB, and typically develops rapidly following injury. Cytotoxic edema results from cellular swelling, membrane breakdown, and ultimately cell death. Clinically significant brain edema usually represents a combination of vasogenic and cytotoxic components. Edema can lead to increased ICP as well as tissue shifts and brain displacement"
        },
        {
            "id": "Pharmacology_Katzung_53",
            "title": "Pharmacology_Katzung",
            "content": "the walls of the capillaries that perfuse the brain. Finally, after bringing about its effect, a drug should be eliminated at a reasonable rate by metabolic inactivation, by excretion from the body, or by a combination of these processes."
        },
        {
            "id": "Physiology_Levy_322",
            "title": "Physiology_Levy",
            "content": "Na+ (mEq/L)148136\u2013145K+ (mEq/L)2.93.5\u20135Cl\u2212 (mEq/L)120\u2013130100\u2013106Glucose(mg/dL)50\u20137570\u2013100Protein(mg/dL)15\u2013456.8\u00d7 103pH7.3 FromWillisWD,GrossmanRG.Medical Neurobiology. 3rded.StLouis:Mosby;1981. ventricles and subarachnoid space, as well as systemic blood pressure. However, the absorption rate of CSF is a direct function of CSF pressure. ObstructionofthecirculationofCSFleadstoincreasedCSFpressureandhydrocephalus,anabnormalaccumulationoffluidinthecranium.Inhydrocephalustheventriclesbecomedistended,andiftheincreaseinpressureissustained,brainsubstanceislost.Whentheobstructioniswithintheventricularsystemorintheforaminaofthefourthventricle,theconditioniscalledanoncommunicating hydrocephalus. Iftheobstructionisinthesubarachnoidspaceorthearachnoidvilli,itisknownasacommunicating hydrocephalus. The Blood-Brain Barrier"
        },
        {
            "id": "Pharmacology_Katzung_2513",
            "title": "Pharmacology_Katzung",
            "content": "Tiagabine is a lipophilic, blood-brain barrier-permeant analog of nipecotic acid, a GABA uptake inhibitor that is not active systemically. The chemical structure of tiagabine consists of the active moiety\u2014nipecotic acid\u2014and a lipophilic anchor that allows the molecule to cross the blood-brain barrier. Tiagabine is highly selective for the GAT-1 GABA transporter isoform, the most abundant GABA transporter expressed in brain, and has little or no activity on the other sodiumand chloride-dependent GABA transporters, GAT-2, GAT-3, or BGT-1. The action of the GABA that is released by inhibitory neurons is normally terminated by reuptake into the neuron and surrounding glia by these transporters. Tiagabine inhibits the movement of GABA from the extracellular space\u2014where the GABA can act on neuronal receptors\u2014to the intracellular compartment, where it is inactive. This action of tiagabine causes prolongation of GABA-mediated inhibitory synaptic responses and potentiation of tonic inhibition;"
        },
        {
            "id": "InternalMed_Harrison_21107",
            "title": "InternalMed_Harrison",
            "content": "that are active at receptor sites. Apart from hyperammonemia, which of these mechanisms is of critical importance is not clear. The mechanism of the encephalopathy of renal failure is also not known. Unlike ammonia, urea does not produce central nervous system (CNS) toxicity, and a multifactorial causation has been proposed for the encephalopathy, including increased permeability of the blood-brain barrier to toxic substances such as organic acids and an increase in brain calcium and cerebrospinal fluid (CSF) phosphate content."
        }
    ],
    "scores": [
        0.03209704813751057,
        0.026141207471130745,
        0.025757575757575757,
        0.025600279745150025,
        0.02540314769975787,
        0.02497648425828584,
        0.024949923111406182,
        0.024308891534708915,
        0.02413207951380667,
        0.023450021363574453,
        0.02306759890380156,
        0.021753476142265082,
        0.01831826018844057,
        0.018187830687830687,
        0.01816545290892726,
        0.016653182308522113,
        0.016584429824561403,
        0.016483516483516484,
        0.01626651050816579,
        0.015931068683362262,
        0.015751937984496124,
        0.015537488708220417,
        0.015270935960591134,
        0.01521164021164021,
        0.015114196148678908,
        0.01488095238095238,
        0.014854753521126762,
        0.014761956640156879,
        0.014697120158887786,
        0.014578408195429472,
        0.014415348716619134,
        0.014321357285429142
    ]
}